Terms: = Leukemia AND CD79B, ENSG00000007312, 974, P40259, IGB, B29 AND Prognosis
15 results:
1. EIF3B Associates with Exacerbated Clinical Features, Poor Treatment Response and Survival in Adult Philadelphia Chromosome Negative Acute Lymphoblastic leukemia Patients.
Zhu F; Fu Y; He X
Technol Cancer Res Treat; 2021; 20():15330338211041464. PubMed ID: 34617851
[No Abstract] [Full Text] [Related]
2. [Chronic lymphocytic leukemia with t(14 ;18) and trisomy 12: a case report].
Le Guyader M; Coude M; Laribi K; Besançon A; Ghnaya H; Denizon N; Defasque S; Pineau-Vincent F; Kaabar M; Lemaire P
Ann Biol Clin (Paris); 2018 Aug; 76(4):445-450. PubMed ID: 29905151
[TBL] [Abstract] [Full Text] [Related]
3.
Coulter EM; Pepper A; Mele S; Folarin N; Townsend W; Cuthill K; Phillips EH; Patten PEM; Devereux S
Haematologica; 2018 Mar; 103(3):497-505. PubMed ID: 29242301
[TBL] [Abstract] [Full Text] [Related]
4. Clinical utility of next-generation sequencing-based minimal residual disease in paediatric B-cell acute lymphoblastic leukaemia.
Sekiya Y; Xu Y; Muramatsu H; Okuno Y; Narita A; Suzuki K; Wang X; Kawashima N; Sakaguchi H; Yoshida N; Hama A; Takahashi Y; Kato K; Kojima S
Br J Haematol; 2017 Jan; 176(2):248-257. PubMed ID: 27861730
[TBL] [Abstract] [Full Text] [Related]
5. Safety and activity of the anti-cd79b antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
[TBL] [Abstract] [Full Text] [Related]
6. The lymphocyte immunophenotypical pattern in chronic lymphocytic leukemia associated with hepatitis viral infections.
Bumbea H; Vladareanu AM; Vintilescu A; Radesi S; Ciufu C; Onisai M; Baluta C; Begu M; Dobrea C; Arama V; Streinu-Cercel A; Arama S
J Med Life; 2011 Aug; 4(3):256-63. PubMed ID: 22567048
[TBL] [Abstract] [Full Text] [Related]
7. Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL.
Lanasa MC; Allgood SD; Slager SL; Dave SS; Love C; Marti GE; Kay NE; Hanson CA; Rabe KG; Achenbach SJ; Goldin LR; Camp NJ; Goodman BK; Vachon CM; Spector LG; Rassenti LZ; Leis JF; Gockerman JP; Strom SS; Call TG; Glenn M; Cerhan JR; Levesque MC; Weinberg JB; Caporaso NE
Leukemia; 2011 Sep; 25(9):1459-66. PubMed ID: 21617698
[TBL] [Abstract] [Full Text] [Related]
8. No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia.
Kim DH; Popradi G; Sriharsha L; Kamel-Reid S; Chang H; Messner HA; Lipton JH
Cancer; 2008 Aug; 113(4):772-81. PubMed ID: 18543309
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study.
Bomben R; Dal Bo M; Capello D; Benedetti D; Marconi D; Zucchetto A; Forconi F; Maffei R; Ghia EM; Laurenti L; Bulian P; Del Principe MI; Palermo G; Thorsélius M; Degan M; Campanini R; Guarini A; Del Poeta G; Rosenquist R; Efremov DG; Marasca R; Foà R; Gaidano G; Gattei V
Blood; 2007 Apr; 109(7):2989-98. PubMed ID: 17148579
[TBL] [Abstract] [Full Text] [Related]
10. A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia.
Zucchetto A; Bomben R; Dal Bo M; Sonego P; Nanni P; Rupolo M; Bulian P; Dal Maso L; Del Poeta G; Del Principe MI; Degan M; Gattei V
J Cell Physiol; 2006 May; 207(2):354-63. PubMed ID: 16331666
[TBL] [Abstract] [Full Text] [Related]
11. B cell response to surface IgM cross-linking identifies different prognostic groups of B-chronic lymphocytic leukemia patients.
Nédellec S; Renaudineau Y; Bordron A; Berthou C; Porakishvili N; Lydyard PM; Pers JO; Youinou P
J Immunol; 2005 Mar; 174(6):3749-56. PubMed ID: 15749915
[TBL] [Abstract] [Full Text] [Related]
12. Signature of B-CLL with different prognosis by Shrunken centroids of surface antigen expression profiling.
Zucchetto A; Sonego P; Degan M; Bomben R; Dal Bo M; Russo S; Attadia V; Rupolo M; Buccisano F; Del Principe MI; Del Poeta G; Pucillo C; Colombatti A; Campanini R; Gattei V
J Cell Physiol; 2005 Jul; 204(1):113-23. PubMed ID: 15605425
[TBL] [Abstract] [Full Text] [Related]
13. Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts.
Rawstron AC; Green MJ; Kuzmicki A; Kennedy B; Fenton JA; Evans PA; O'Connor SJ; Richards SJ; Morgan GJ; Jack AS; Hillmen P
Blood; 2002 Jul; 100(2):635-9. PubMed ID: 12091358
[TBL] [Abstract] [Full Text] [Related]
14. Morphological and immunophenotypic features of chronic lymphocytic leukemia.
Matutes E; Polliack A
Rev Clin Exp Hematol; 2000 Mar; 4(1):22-47. PubMed ID: 11486329
[TBL] [Abstract] [Full Text] [Related]
15. Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia.
Avet-Loiseau H; Garand R; Gaillard F; Daviet A; Mellerin MP; Robillard N; Bouyge I; Arcot S; Batzer M; Talmant P; Harousseau JL; Milpied N; Bataille R
Genes Chromosomes Cancer; 1998 Oct; 23(2):175-82. PubMed ID: 9739021
[TBL] [Abstract] [Full Text] [Related]
